Table 5.
Stimulus | AG1478 (nmol/L) | Inhibition (%) | N |
---|---|---|---|
Complement | 300 | 62 ± 7* | 4 |
EGF | 300 | 100 ± 1* | 4 |
30 | 52 ± 24† | 4 | |
3 | 0 | 2 | |
PMA | 300 | −15 ± 10‡ | 4 |
GEC were untreated or were preincubated with AG1478 for 15 minutes at 37°C, then incubated with complement, EGF, or PMA (as in Figure 6 ▶ ). ERK2 tyrosine204 phosphorylation was monitored by immunoblotting and quantitated by densitometry. Inhibition was determined by comparing stimulated increases in ERK2 tyrosine204 phosphorylation with and without AG1478.
*P < 0.0001,
†P = 0.06 versus untreated.
‡Negative value indicates a trend toward stimulation in the presence of AG1478.